Acusphere (ACUS) Stock Price, News & Analysis

Company Overview

Acusphere, Inc. is a pharmaceutical company that historically focused on developing and commercializing products based on its proprietary drug-delivery technologies. The company’s platform was designed to create inhaled and injectable formulations intended to improve the delivery and performance of existing pharmaceutical compounds.

Acusphere’s best-known product was Imagify, also known as perflubutane polymer microspheres or AI-700. Imagify was developed as an ultrasound contrast agent to assist physicians in evaluating myocardial perfusion, or blood flow to the heart muscle. The product received approval from the U.S. Food and Drug Administration in 2008.

The company was based in the United States and primarily pursued opportunities in the U.S. pharmaceutical and medical-imaging markets. Publicly available information about Acusphere’s current operations, product portfolio and leadership is limited, and the company’s historical business activities appear to have centered on its earlier development programs rather than a broad active commercial operation.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ACUS
• CIK: N/A
• Web: www.acusphere.com
• Phone: (617) 648-8800
• Fax: 978-863-9993
• Employees: 118
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A